×

Is There Any Difference in Prognosis Between Synchronous and Metachronous Brain Metastasis From Metastatic Renal Cell Carcinoma?
Prognostic Value of Vascular Endothelial Growth Factor (VEGF), VEGF receptor 2, Platelet-Derived Growth Factor-β (PDGF-β), and PDGF-β Receptor Expression in Papillary Renal Cell Carcinoma
Functional Change of Contralateral Kidney After Partial Nephrectomy Using Diethylene Triamine Penta?acetic Acid (DTPA) Renal Scintigraphy: Long Term Analysis
The benefits of adjuvant chemotherapy after radical cystectomy with pelvic lymph node dissection in patients with urothelial carcinoma of bladder according to the lymph node density on final pathology
Predicting Factors of Renal Function Decline after Radical Nephrouretectomy for Upper Tract Urothelial Carcinoma : Correlation with Results of Preoperative 99mTc-Diethylenetriamine Pentaacetic Acd(DTPA)
Differences of Oncologic outcomes of Prostate Cancer with Nodal Metastasis in the Absence of Distant Metastasis According to Initial Treatment
Temsirolimus versus VEGFR TKIs for Patients with Metastatic Non-clear-Cell Renal Cell Carcinoma
Risk factors for Upstaging in Patients with Low Risk Prostate Cancer using K-CaP Registry
Clinicopathological Features of Patients Progressed into Castration-Resistant Prostate Cancer after Radical Prostatectom
Oncologic Outcome of an Incidental Pathological T3a Stage after Partial Nephrectomy in Small Renal Cell Carcinoma
3rd course of Bacillus Calmette-Gu?rin instillation to the patients with primary CIS of bladder : Is it safe?
Indolent clinical outcomes of CIS-associated pTa bladder tumor after Bacillus Calmette-Gu?rin : Need for a new classification of CIS
Role of Diffusion-Weighted MR Imaging in the Discrimination of Local Recurrence after Radical Prostatectomy for Prostate Cancer
RandomizEd phase II trial of Sunitinib four-week on and two-week off vs.Two-week On and one-week off in metastatic clear cell type REnal cell carcinoma: RESTORE trial (NCT00570882)
Analysis of preoperative variables to identify patients who would likely benefit from upfront cytoreductive nephrectomy
Prognostic Value of Body Mass Index in Patients who Received Radical Cystectomy for Muscle-Invasive Bladder Cancer
VEGF/VEGFR2 or PDGF-β/PDGFR-β expression in non-metastatic, renal cell carcinoma : a prospective study with 1,091 consecutive cases
Association Between an Intravesical Prostatic Protrusion And a Positive Prostatic Base Margin After Robot-Assisted Radical Prostatectomy
Accuracy of FDG PET-CT Compared with Conventional CT for the Lymph Node Staging in Muscle invasive Bladder Cancer : Prospective Study of 58 Patients with Extended Lymphadenectomy
PSA response rate of second-line chemotherapy in castration-resistant prostate cancer : Single center Experience in Korea
Activity of gemcitabine-oxaliplatin (GemOx) plus prednisolone in patients with castration-resistant prostate cancer (CRPC) for whom docetaxel-based chemotherapy failed
Comparative Efficacy of Sunitinib versus Sorafenib as First-line Treatment for Patients with Metastatic Renal Cell Carcinoma
Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI) is Active in Patients with Metastatic Renal Cell Carcinoma (mRCC) with Poor Risk Features
Oncological Outcome after Open Versus Laparoscopic Radical Nephrectomy for Stage cT2a Renal Cell Carcinoma
Is There A Role for Partial Nephrectomy for Renal Tumors Regarding Overall Survival in Patients Older than 70 year?
Clinical Significance of Benign Prostatic Tissue at Soft Tissue Margin in Robotic and Open Radical Prostatectomy
Primary Treatment Patterns in Localized High-risk Prostate Cancer
Hand-Assisted Laparoscopic Nephroureterectomy with a Bladder Cuff Excision and Immediate Mitomycin C Instillation
Usefulness of Free/total PSA Ratio in Patients who Had Elevated PSA after BCG Instillation for Bladder Cancer
Impact of Tamsulosin on Urinary Retention Following Early Catheter Removal after Robot-Assisted Laparoscopic Radical Prostatectomy: A Prospective Randomized Controlled Tria
Primary urethral cancer: A retrospective analysis of 27 patients at a single institute
Lower concentration of serum insulin-like growth factor is independently associated with high grade prostate cancer
Does the primary lesion have to be regarded as a target lesion when evaluating response in metastatic renal cell carcinoma (mRCC) treated with sunitinib?
Clinical characteristics, survival and prognostic factors of advanced renal cell carcinoma with predominant sarcomatoid histology
Role of molecular markers in nephrectomyspecimenas prognosticators for patients with metastatic renal cell carcinomain the era of targeted therapy
Development of Muscle Invasive Bladder Cancer after Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
Time Trends of Tumor Aggressiveness for Prostate Cancer: Single Center Experience
Prognosis of Prostate Cancer with other priamry malignancies
Side Specific Prediction of Extracapsular Extension in Clinically Localized Prostate Cancer: The Role of Diffusion-Weighted 3T MR Imaging
Can we Apply the Western Criteria for Prediction of Clinically Significant Prostate Cancer in Korean Men?